Viridian Therapeutics, Inc. (VRDN)

29.24 -0.16 (-0.54%) USD  |  NASDAQ  |  Feb 25, 12:03
More

Viridian Therapeutics Commercial Paper Liability (Quarterly)

Commercial Paper Liability (Quarterly) Chart

View Commercial Paper Liability (Quarterly) for VRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Commercial Paper Liability (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Commercial Paper Liability (Quarterly) Range, Past 5 Years

View Commercial Paper Liability (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Commercial Paper Liability (Quarterly) Benchmarks

View Commercial Paper Liability (Quarterly) Benchmarks
Start Trial
Marker Therapeutics, Inc. --
ADMA Biologics, Inc. --
Avantor, Inc. --
Immunovant, Inc. --
Plus Therapeutics, Inc. --